Gender Parity Panel Discussion


On September 30, 2020, the community of Women in the Enterprise of Science & Technology (WEST) will be featuring those who have championed the advancement of women throughout Massachusetts. 
We will also reflect on ways we can challenge ourselves to expand and build on these accomplishments.

The panel will include leaders from the industry and academic sectors, who have advocated for gender parity in science and technology. Panelists include Anisha Asundi, Research Fellow: Gender Specialist, Women and Public Policy Program at Harvard Kennedy School, Caroline BreitbachVP R&D Programs and Strategy at Turnstone Biologics, Lucy Perez, Senior Partner at McKinsey & Company, and Alicja Januszewicz, Head of People & Culture at Allena Pharmaceuticals, Inc. 

They will be discussing the strategies they have explored and the advances already adopted by pharma and other industries to achieve greater gender parity and the advancement of more women into executive leadership roles. They will weave in legislative gains in MA, such as the Paid Family Leave Act and the 2019 MA Equal Pay Act. In addition, they will report on the latest gains in gender diversity in the science and technology industries, describing the impact it has had, and demonstrate how research can further support equal opportunities for women across their career journey.

  

Date and Time:
September 30, 2020
6:00 - 7:30 PM


Location:
Zoom

Cost:
$5 for Members, $15 for non-members

Cancellation Policy:
All programs are non-refundable.

Download Event Flyer

 

Register Here


Become a sponsor and contribute to a great cause.  For more information, email [email protected] or call 857-600-2598.   

 

 

Thank You to Our Event Sponsors

   

 Home - Scholar Rock 

 

Panelist Bios

Anisha Asundi, MPH, is currently a Research Fellow: Gender Specialist at the Women and Public Policy Program at the Harvard Kennedy School. At WAPPP, she manages the Gender Action Portal (gap.hks.harvard.edu) by editing and vetting articles for the Portal and by providing content management for the website. She also works on WAPPP's Gender and Technology portfolio - which aims to increase the wealth of research on how to close the tech gender gap and advance D&I in tech fields. She is a co-chair of Harvard's Women in Techn+Allies affinity group, seeking to advance gender representation, engagement, and support in STEM and technology-related fields at Harvard. Her research experience, academic knowledge and practical work lies in the foundations of inclusion and health equity - particularly in increasing the wealth of research among marginalized populations such as women, people of color, LGBTQ communities and low-income populations, and in quantitatively and qualitatively evaluating intervention programs for these populations in our organizations and communities. She has a MPH, with a concentration in Health Disparities and Social-Behavioral Science, from Boston University School of Public Health, and a BA in Psychology from Skidmore College.

Caroline J Breitbach is Vice President, R&D Programs and Strategy at Turnstone Biologics, focusing on the development of oncolytic viral immunotherapies for the treatment of patients with advanced cancers. Caroline was previously Vice President, Clinical & Translational Research at SillaJen Biotherapeutics (formerly Jennerex Biotherapeutics), where she oversaw Phase 1 and 2 clinical studies of an oncolytic vaccinia virus. Caroline received her undergraduate degree at McGill University in Montreal, Canada and her PhD in Dr John Bell’s group at the University of Ottawa in Ottawa, Canada.

Lucy Pérez is a Senior Partner in McKinsey’s Boston office and a leader in the Pharmaceuticals and Medical Products practice with deep expertise in new product planning and product strategy, leveraging data and analytics to maximize patient benefit, demonstrate product value, and catalyze innovation. She is the leader of McKinsey’s Hispanic and Latino Network and co-leader of Greater Boston Women’s Initiative. She is passionate about driving diversity, equity, and inclusion. Lucy’s clients include large pharmaceutical companies, biotechs, data players, and academic medical centers in the US, Europe, Latin America, and Asia. Lucy has a PhD in Chemistry from Harvard University, where she also earned a Bachelor of Arts and a Master of Arts in Organic Chemistry. Before McKinsey, Lucy was a Research Fellow at Memorial Sloan-Kettering Cancer Center, and she is the co-author of multiple peer-reviewed publications and patents.  

 


 

 

20th Anniversary